Colgate-Palmolive’s (CL) Sector Perform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their sector perform rating on shares of Colgate-Palmolive (NYSE:CL) in a report issued on Wednesday,Benzinga reports. They currently have a $101.00 price target on the stock.

A number of other analysts have also recently commented on CL. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays decreased their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Finally, Stifel Nicolaus decreased their price target on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $102.00.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $86.64 on Wednesday. The company has a market capitalization of $70.78 billion, a P/E ratio of 24.82, a P/E/G ratio of 3.70 and a beta of 0.44. The business has a fifty day simple moving average of $91.52 and a two-hundred day simple moving average of $97.25. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 405.81% and a net margin of 14.27%. During the same period last year, the company posted $0.87 earnings per share. On average, analysts expect that Colgate-Palmolive will post 3.58 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Institutional investors have recently made changes to their positions in the business. Algert Global LLC boosted its holdings in Colgate-Palmolive by 14.4% during the 2nd quarter. Algert Global LLC now owns 5,131 shares of the company’s stock valued at $498,000 after acquiring an additional 647 shares during the period. NewEdge Advisors LLC boosted its stake in shares of Colgate-Palmolive by 11.7% during the second quarter. NewEdge Advisors LLC now owns 51,375 shares of the company’s stock valued at $4,985,000 after purchasing an additional 5,363 shares during the period. B. Riley Wealth Advisors Inc. grew its holdings in shares of Colgate-Palmolive by 7.3% in the second quarter. B. Riley Wealth Advisors Inc. now owns 17,851 shares of the company’s stock worth $1,732,000 after purchasing an additional 1,212 shares during the last quarter. SPC Financial Inc. purchased a new position in shares of Colgate-Palmolive in the second quarter worth $227,000. Finally, 3Chopt Investment Partners LLC bought a new stake in Colgate-Palmolive during the 2nd quarter valued at $400,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.